myDNA Pharmacogenomic Test

Fast-track healthcare goals and enable personalization for every patient with pharmacogenomic-guided prescribing.

Clinic Sign-inPay My Bill
Two medical professionals at a table discussing a report

Fast-track healthcare goals and enable personalization for every patient with pharmacogenomic-guided prescribing.

Clinic Sign-in

What is a
Pharmacogenomic Test?

Pharmacogenomics (PGx) is the study of how genetic variations influence the way an individual responds to medications.

PGx is now enabling doctors to test for specific genetic changes to predict whether a patient may have a normal response, a poor response, or a higher risk of side effects before prescribing a specific medication.

Tests We Offer

We offer two PGX Tests:

myDNA Psychotropic Test

Covering over 41 psychotropic medications used in clinical practice. Find out more about the Psychotropic test.

myDNA Multiple Category Test

Covering over 160 medications used in clinical practice. Find out more about the Multiple Category Test.

PGX Testing Benefits

  • May help reduce the risk of experiencing medication side effects.

    By testing certain genetic markers, the risk of possible side effects may be predicted even prior to starting the medication. This can help personalize dosage and choice of medication.

  • May reduce some of the guesswork around medication selection.

    PGx testing may help to reduce some of the "trial and error" that can be involved in prescribing medications. The myDNA test provides you with information that can further assist in prescribing an effective medication sooner, potentially saving you and your patient time and money.

  • Results last a lifetime.

    The test results presented in the report will assist you and your patient, now and in the future, to decide if one of the covered medications is right for your patient.

myDNA Psychotropic PGX Test

The myDNA Psychotropic Test is a PGx test that analyzes how certain genetic variations may affect the response to a range of psychotropic medications used in the treatment of depression, anxiety, ADHD, and other mental health conditions.

Our PGx reports are simple and easy for you to follow and share with your patient. All PGx reports include detailed interpretations and recommendations with references to international PGx guidelines for each gene-drug pair, including suggestions of how to adjust dosages, and where appropriate, to select an alternative medication.

Request Sample Report

Medications Covered

The following is a list of medications with pharmacogenomic associations that are included in the myDNA psychotropic medication PGx report.

Amitriptyline
Amoxapine
Amphetamine
Aripiprazole
Aripiprazole lauroxil
Atomoxetine
Brexpiprazole
Bupropion
Carbamazepine
Chlorpromazine
Citalopram
Clobazam
Clomipramine
Clozapine
Dextroamphetamine
Diazepam
Doxepin
Duloxetine
Escitalopram
Fluoxetine
Flupenthixol
Fluvoxamine
Haloperidol
Iloperidone
Imipramine
Lisdexamfetamine
Mirtazapine
Nortriptyline
Olanzapine
Oxcarbazepine
Paroxetine
Perphenazine
Pimozide
Protriptyline
Quetiapine
Risperidone
Sertraline
Trimipramine
Venlafaxine
Viloxazine
Vortioxetine


Non-italicized medications – Clinical recommendations from evidence-based guidelines (e.g. CPIC, DPWG) and/or regulatory bodies (e.g. FDA) are provided where relevant.

Italicized medications – pharmacogenomic results have limited impact on these medications based on the current evidence-based guidelines.

Genes Covered

The myDNA Psychotropic test covers a broad range of genes which covers up to 14 genes relevant for psychotropic medications.

myDNA Psychotropic PGx Genes
CYP2D6
CYP2C19
CYP2C9
CYP2B6
CYP1A2
CYP3A4
HLA-A*31:01
HLA-B*15:02
myDNA Psychotropic PGx Emerging Genes
CES1A1
ADRA2A
UGT1A4
UGT2B15
SLC6A4
HTR2A

myDNA Multiple Category Test

The myDNA Multiple Category Test is a PGx test that analyzes how certain genetic variations may affect the response to a range of medications used in various medical specialities such as psychiatry, cardiology, gastroenterology, and pain medicine.

Our PGx reports are simple and easy for you to follow and share with your patient. All PGx reports include detailed interpretations and recommendations with references to international PGx guidelines for each gene-drug pair, including suggestions of how to adjust dosages, and where appropriate, to select an alternative medication.

Request Sample Report

Medication Categories

The main medical categories that are covered are highlighted below; however, insights into other medications are also included with the Multiple Category test.

Medications Covered

The following is a list of medications with pharmacogenomic associations that are included in the myDNA Multiple Category Medication PGx report.

Download Substrate Card

Inquire about Pharmacogenomic Services Online

Are you interested providing the myDNA Psychotropic PGx test to your patients? Submit your information below and we will contact you to help you get started.

Please note: the myDNA PGx test must be ordered by a registered clinician. If you are a patient/caregiver interested in testing, please contact your clinician. Our clinician registration process is simple, quick, and easy.

Note: For individuals interested in these services, please speak to your healthcare professional.

Thank you!

Your submission has been received. Our laboratory will be in touch soon to follow up your enquiry.
An error occurred while submitting the form. Please try again. If the issue persists, please contact our support team.